Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 3,000 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $41.40, for a total value of $124,200.00. Following the completion of the sale, the director now directly owns 78,409 shares […]
StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. Separately, Bank of America began coverage on shares of Amphastar Pharmaceuticals in a research note on Friday, November 17th. They set a neutral rating and a $63.00 price objective on […]
Amphastar Pharmaceuticals, Inc (NASDAQ:AMPH) COO Sells $7,875,640 92 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $61.37, for a total transaction of $30,685.00. Following the sale, the director now owns 80,833 shares in the […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data on Wednesday, November 8th. Parties interested in listening to the company’s conference call can do so using this link. Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) last issued its quarterly earnings results on Tuesday, August 8th. The company reported […]